Trials / Sponsors / Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast C Prevention of Chemotherapy-induced Myelosuppression | Phase 1 | 2023-01-09 |
| Terminated | A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection) Non Small Cell Lung Cancer, Small-cell Lung Cancer | Phase 1 | 2019-09-03 |
| Completed | Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2016-09-01 |
| Completed | ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma | Phase 1 / Phase 2 | 2014-10-01 |
| Completed | Phase 1 Safety Study of ALRN-5281 in Healthy Subjects Growth Hormone Deficiency | Phase 1 | 2013-01-01 |